Study protocol for the Multimodal Approach to Preventing Suicide in Schools (MAPSS) project: a regionally based randomised trial of an integrated response to suicide risk among secondary school students

. 2022 Mar 2;23:186. doi: 10.1186/s13063-022-06072-8

Title	Study protocol for the Multimodal Approach to Preventing Suicide in Schools (MAPSS) project: A regionally-based trial of an integrated response to suicide risk among secondary school students.
Trial registration	Australian New Zealand Clinical Trial Registry, ACTRN12621000279820 12.03.2021 https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=381921&isClinicalTrial=False
Protocol version	24^Th November 2021, version 2.0
Funding	This research is funded by the National Health and Medical Research Council (NHRMC), Australia (GNT1153051). [See Additional file 1 for copy of the original funding documentation]
Author details	¹Orygen, Parville, Australia ²Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia ³Centre for Mental Health, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia ⁴Deakin University, Geelong, Deakin Health Economics, Institute for Health Transformation, School for Health and Social Development, Faculty of Health, Australia ⁵Department of Psychological Medicine, The University of Auckland, Auckland, New Zealand ⁶School of Public Health, The University of Queensland, Brisbane, Australia ⁷Policy and Epidemiology Group, Queensland Centre for Mental Health Research, Brisbane, Australia
Name and contact information for the trial sponsor	Orygen, 35 Poplar Road, Melbourne, Australia + 61 3 9342 2800 research@orygen.org.au
Role of sponsor and funder	This is an investigator-initiated research project which has been funded by non-commercial sources. The role of the funder (National Health and Medical Research Council) and Sponsor (Orygen) will not impact on decisions regarding the outcome of this research or how it will be published. Orygen (as Sponsor) has taken an active role in the monitoring of the study as both Orygen and the funder require the studies to be conducted in accordance with local regulatory guidelines and industry best practice. However, the research and its outcomes are independent of both the Sponsor and the Funder.